RCAN3
Calcipressin-3
Also known as: DSCR1L2, RCAN3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UKA8
- Gene
- RCAN3
- Ensembl
- ENSG00000117602
- Chromosome
- 1
- Canonical length
- 241 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoli fibrillar center,Nuclear speckles
OverviewNCBI Gene
Enables phosphatase binding activity and troponin I binding activity. Predicted to be involved in calcium-mediated signaling. Predicted to be located in cytosol. Predicted to be active in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
241 residues, UniProt reviewed canonical sequence.
>Q9UKA8|RCAN3
1 MLRDTMKSWN DSQSDLCSTD QEEEEEMIFG ENEDDLDEMM DLSDLPTSLF ACSVHEAVFE
61 AREQKERFEA LFTIYDDQVT FQLFKSFRRV RINFSKPEAA ARARIELHET DFNGQKLKLY
121 FAQVQMSGEV RDKSYLLPPQ PVKQFLISPP ASPPVGWKQS EDAMPVINYD LLCAVSKLGP
181 GEKYELHAGT ESTPSVVVHV CESETEEEEE TKNPKQKIAQ TRRPDPPTAA LNEPQTFDCA
241 LLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RCAN3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.53
- Highest tissue expression
- 32 nTPM
Expression across tissuesHPA
Tissue
- prostate: 32 nTPM
- cerebellum: 28 nTPM
- lymph node: 19 nTPM
- tonsil: 18 nTPM
- stomach: 16 nTPM
- thymus: 15 nTPM
Single-cell type
- prostatic glandular cells: 378 nCPM
- fallopian tube ciliated cells: 218 nCPM
- respiratory ciliated cells: 194 nCPM
- endometrial ciliated cells: 179 nCPM
- alveolar cells type 1: 174 nCPM
- t-cells: 168 nCPM
Immune cell
- T-reg: 38 nTPM
- naive CD4 T-cell: 33 nTPM
- memory CD4 T-cell: 25 nTPM
- naive CD8 T-cell: 18 nTPM
- MAIT T-cell: 10 nTPM
- memory CD8 T-cell: 9 nTPM
Brain region
- cerebellum: 58 nTPM
- pons: 22 nTPM
- medulla oblongata: 18 nTPM
- midbrain: 18 nTPM
- hypothalamus: 18 nTPM
- thalamus: 16 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.31
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.63
- DepMap mean gene effect
- 0.11
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- calcium-dependent protein serine/threonine phosphatase regulator activity
- phosphatase binding
- RNA binding
- troponin I binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
InteractionsUniProt · HPA
Protein binding partners of RCAN3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RCAN3 as an antibody target. Whether an autoantibody or antibody against RCAN3 could matter depends on whether native RCAN3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RCAN3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RCAN3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...